07:38 AM EDT, 08/06/2025 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Q2 net income Wednesday of $30 million, down from $102 million a year earlier.
Total income and other revenue for the quarter ended June 30 were $579 million, up from $537 million a year earlier.
Analyst estimates were not readily available for comparison.